Have a personal or library account? Click to login
Quantitation of red cell-bound immunoglobulins and complement in lymphoma patients Cover

Quantitation of red cell-bound immunoglobulins and complement in lymphoma patients

Paid access
|Oct 2020

Abstract

Quantitative ELISA may be useful for determining the amount of red blood cell (RBC)-associated immunoglobulins (Igs) in patients with autoimmune hemolytic anemia (AIHA). In idiopathic AIHA, there is about 20 times more RBC-associated IgG and complement than in normal persons. In patients with low-grade lymphomas (particularly, B-CLL and splenic marginal zone lymphoma) autoimmune hemolysis is a component of their anemia. In highgrade malignant lymphomas (i.e, diffuse large B-cell lymphoma and peripheral T-cell lymphoma), as well as in Hodgkin’s disease, autoimmune hemolysis contributes little, if any, anemia. The quantitative ELISA for RBC-associated IgG and complement is useful for following the effects of treatment in patients with immune hemolysis. Immunohematology 2000; 16:147–153.

DOI: https://doi.org/10.21307/immunohematology-2019-597 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 147 - 153
Published on: Oct 18, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 M. Podberezin, A. Levina, L. Romanova, O. Margolin, O. Nasibov, A.V. Pivnik, published by American National Red Cross
This work is licensed under the Creative Commons License.